SOST and osteoporosis: To examine whether targeting sclerostin loop3 by the specific in vivo pharmacologic tool Apc001PE could promote bone formation, increase bone mass, and improve bone microarchitecture integrity in rats with established osteoporosis induced by OVX, SD rats were grouped and treated accordingly (Supplementary Figs. 17a and 18).